79 related articles for article (PubMed ID: 15194288)
1. Expression of cyclooxygenases during renal allograft rejection.
Rangel EB; Moura LA; Franco M; Pacheco-Silva A
Transplant Proc; 2004 May; 36(4):838-9. PubMed ID: 15194288
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection.
Rangel EB; Moura LA; Franco MF; Pacheco-Silva A
Clin Transplant; 2005 Aug; 19(4):543-50. PubMed ID: 16008603
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human renal allograft rejection-- a prospective study.
Hoffmann U; Banas B; Krüger B; Pietrzyk M; Obed A; Segerer S; Kammerl M; Rümmele P; Riegger GA; Krämer BK
Transpl Int; 2006 Mar; 19(3):203-12. PubMed ID: 16441769
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of cyclooxygenase-2 in different grades of acute human renal allograft rejection.
Rangel EB; Moura LA; Franco MF; Pacheco-Silva A
Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):235-43. PubMed ID: 17382527
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in biopsies obtained from human transplanted kidneys undergoing rejection.
Hausknecht B; Voelkl S; Riess R; Gauer S; Goppelt-Struebe M
Transplantation; 2003 Jul; 76(1):109-14. PubMed ID: 12865795
[TBL] [Abstract][Full Text] [Related]
6. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells.
van der Leij J; van den Berg A; Albrecht EW; Blokzijl T; Roozendaal R; Gouw AS; de Jong KP; Stegeman CA; van Goor H; Chang NS; Poppema S
Transplantation; 2003 Jun; 75(12):2076-82. PubMed ID: 12829915
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T; Shearer T; Azuma M
Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury.
Feitoza CQ; Câmara NO; Pinheiro HS; Gonçalves GM; Cenedeze MA; Pacheco-Silva A; Santos OF
Int Immunopharmacol; 2005 Jan; 5(1):79-84. PubMed ID: 15589463
[TBL] [Abstract][Full Text] [Related]
11. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
12. Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation.
Kolaczkowska E; Goldys A; Kozakiewicz E; Lelito M; Plytycz B; van Rooijen N; Arnold B
Arch Immunol Ther Exp (Warsz); 2009; 57(6):459-66. PubMed ID: 19885646
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
14. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-1 and -2 in human breast cancer.
Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K
Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived interleukin-18 in experimental renal allograft rejection.
Wyburn K; Wu H; Yin J; Jose M; Eris J; Chadban S
Nephrol Dial Transplant; 2005 Apr; 20(4):699-706. PubMed ID: 15716294
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor expression in patients with renal allograft dysfunction.
Kwon J; Park J; Lee D; Kim YS; Jeong HJ
Transplant Proc; 2008 Dec; 40(10):3479-80. PubMed ID: 19100417
[TBL] [Abstract][Full Text] [Related]
18. Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection.
Pietrzyk MC; Banas B; Wolf K; Rümmele P; Woenckhaus M; Hoffmann U; Krämer BK; Fischereder M
Transplant Proc; 2004 Nov; 36(9):2659-61. PubMed ID: 15621116
[TBL] [Abstract][Full Text] [Related]
19. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
